New biochemical markers in the assessment of minor myocardial damage in critically ill patients;Novi biokemijski biljezi u procjeni malog oštećenja miokarda u životno ugroženih bolesnika

Acta Medica Croatica

Volumn 58, Issue 5, 2004, Pages 381-387

  Cubrilo Turek M ^a   Topic E ^b   Ivanisevic M ^b   Simundic A M ^b   Kern, J ^c   Pilas V ^a  

^a Croatian Academy of Medical Sciences   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; ISOENZYME; TROPONIN;

ADULT; AGED; ARTICLE; BLOOD; CRITICAL ILLNESS; FEMALE; HEART DISEASE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATINE KINASE; CRITICAL ILLNESS; FEMALE; HEART DISEASES; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; TROPONIN;

EID: 15744381215     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
2. Campion EW, Mulley AG, Goldstein RL, Bamett O, Thibault GE. Medical intensive care for the elderly. JAMA 1981; 246: 2052-6.
3. Fedullo AJ, Swinburne AJ. Relationship of patient age to cost and survival in medical ICU. Crit Care Med 1983; 11: 155-9.
4. Travis KW, Carson HS III, Uhl RR, Bendixen HR Report on the first zeal's activities of a multidisciplinary respiratory intensive care unit. Crit Care Med 1973; 1:
5. World Health Organization. Report of the Joint International Sodety and Federation of Cardiology/World Health Organization. Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59: 607-9.
6. Lee TH, Rouan GW, Weisberg MC i sur. Sensitivity of routine dinical criteria for diagnosing myocardial infarction within 24 h of hospitalization. Ann Intern Med 1987; 106: 181-6.
7. Katus HA, Remppis A, Neumann FJ i sur. Kag-nostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-12.
8. Falahati A, Sharkey SW, Christensen D i sur. Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction. Am Heart J 1999; 137: 332-7.
9. Mair J, Morandell D, Gesner N, Lechkitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase Isfe mass, creatine kinase iso-form ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995; 41: 1266-72.
10. Juriander B, Qemmensen P, Wagner GS, Grande P. Very eariy diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac tropoiun-T, myoglobin, and creatine kinase MB mass. Eur Heart J 2000; 21: 382-9.
11. Petersson T, Ohlasson O, Tiyding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarction. A risk indicator of coronary death. Eur Heart J 1992; 13: 1387-92.
12. deWinter RJ, Koster R, Sturk A, Sanders GT. Value of myogjobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995; 92: 3401-7.
13. Mair J, Genser N, Morandell D i suf. Cardiac troponin I in diagnosis of myocardial injury and infarction. Clin Chim Acta 1996; 245: 19-38.
14. de Winter RJ, Koster RW, Schotveld JH, Sturk A, van Straalen JP, Sanders GT. Prognostic value of boponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. Heart 1996; 75: 235-9.
15. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable anrina. BMJ 1996; 313: 262-1.
16. Ottani F, Galvani M, Ferini D i sur. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina. Am Heart J 1999; 137: 284-91.
17. Goldman L, Cook EF, Johnson PA, Brand DA, Rouan GW, Lee TH. Prediction of the need for intensive care in patients who come to emergency departments with acute chest pain. N Engl J Med 1996; 334: 1498-504.
18. Hamm CW, Goldman BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room hiage of patients with acute chest pain by means of rapid testing for caidiac troponin T or troponin I N Engl J Med I997. 337: 1648-53.
19. Polanczyk CA, Lee TH, Cook EF i sur. Cardiac hxjponin I as a predktor of major cardiac events in emergency department patients with acute diest pain. J CoD Caidiol 1998; 32: 8-14
20. Fernandez CJJr, Akamine N, Knobel E Cardiac troponin: a new serum marker of myocardial injury sepsis. Intensive Care Med 1999; 25: 1165-1168.
21. Ammann P, Fer T, Minder EI, Gunter C, Bertel O. Elevation of hoponin I in sepsis and septic shock. Intensive Care Med 2001; 27: 965-9.
22. Elstver KM Cardiac troponins and T are biological markers of left ventricular dysfimction in septic shock. Clin Chem 2000; 46: 650-7.
23. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-8.
24. Bonnefoy E, Godon P, Kirorian G, Fatenti M Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis Eur Heart J 2000; 21: 832-6.
25. Lauer B, Niederau C, Kuhl U i sur. Cardiac tro-ponin T in patients with clinically suspected myocarditis Am Coll Cardiol 1997; 30: 1354-9.
26. Goldmann BU, Christenson RH, Hamm CW, Meinertz T, Ohman EM. Implications of troponin testing clinical medicine. Curr Control Trials Cardiovasc Med 2001; 2: 75-84
27. Douketis p, Crowther MA, Staton EB, Ginsberg JS. Hevated cardiac troponin levels in patients with sub-massive pulmonary embolism. Arch Intern Med 2002; 162; 79-81.
28. Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem 2000; 46: 1345-50.
29. Panteghini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposal. Dostupno na URL adresi: htpp: //www.ifcc.org/ejifcc/voll4noai402062003014pdf. Datum prishipa informaciji 26. srpnja 2003.
30. Ammann P, Maggiorini M, Bertel O i sur. Troponin as a risk factor for mortality in critical ill patient without acute coronary syndrome. J Am Coll Cardiol 2003; 41: 2004-9.
31. Burlina A, Zaninnoto M, Secchiero S, Rubin D, Accorsi F. Troponin T as a marker of ischemic myocardial injury. Clin Biochem 1994; 27/2: 113-21.
32. Heeschen C, Goldmann BU, Moeller RH, Hamm CW. Analytical performance and dinical application of a new rapid bedskle assay for the detection of serum cardiac troponin I. Clin Chem 1998; 44: 1925-30.
33. Brandt DR, Gates RC, Eng KK i sur. Quantifying the MB isoenzyme of creatine kinase with the Abbott «IMx» immunoassay analyzer. Clin Chem 1990, 36: 653-658.
34. Mair J, MoiandeD D, Genser N, Ledileitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase iso-form ratios, and cardiac troponins 1 and T for acute myo-cardial infarction. Clin Chem 1995; 41: 1266-72.
35. Zweig MH, Cammpbell G. Receiver-Operating Characteristic (ROC) plots: A fundamental evaluation tool in clinical medidne. Clin Chem 1993; 39/4: 561-77.
36. Galen RS, Peters T. Analytical goals and dinical relevance of laboratory procedures. U: Tietz NW, ur. Fundamentals of clinical chemistry. 2. izd. Philadelphia, Pennsylvania 19106. WB Saunders Comp, 1994, 213-24.
37. Wu AH. Biochemical markers of cardiac damage; from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM). Scand J din Lab Invest Suppl 1999; 230: 74-82
38. Apple FS, Falahati A, Paulsen PR, Miller EA, Shartey SW. Improved detection of minor ischemic myocardial injury with measurements of serum cardiac troponin I. din Chem 1997; 43; 2047-51.
39. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non Q-wave myocardial infarction; results of the TTMI HIE trial: Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: 1545-6.
40. Antman EM, Gnidzien CG, Sacks DB. Evaluation of rapid bedside assay for detection of serum cardiac troponin T. JAMA 1995; 273: 1279-82.
41. deWinter R, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995; 92; 3401-7.
42. Meinertz T, Hamm CW. Rapid testing for cardiac troponins in patients with acute chest pain in the emergency room. Eur Heart J 1998; 19: 973-4.
43. Wu AHB, Lane PL. Meta analysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart disease. Clin Chem 1995; 41: 1228-33.
44. Mair J, Smidt J, Lechleitner P, Dienstl F, Puschendorf B. A decision tree for early diagnosis of acute myocardial infarction in nontraumatic chest pain patients at hospital admission. Chest 1995; 108: 1502-9.
45. Stubbs P. The cardiac troponins: uses in routine clinical practice. Experiences fiom GUSTO and other clinical trials. Eur Heart J 1998; 19 Suppl N: N59-N63.
46. Newby LK, Christenson RH Ohman EM i sur. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndrome. Circulation 1998; 98: 1853-9.
47. Alonsozana GL, Christenson RH. The case for cardiac troponin T; marker for effective risk stratification of patients with acute cardiac ischemia. Clin Chem 1996; 42: 803-8.
48. Antman EM, Tanasijevic MJ, Thompson B i sur. Cardiac specific troponin I levels to predict the risk of mortality in patients writh acute coronary syndrome. N Engl J Med 1996; 335: 1342-9.
49. Lindal B, Gerhardt W. Biochemical markers enable early diagnosis of myocardial damage. Lakartidningen 1998; 95: 3034-8.
50. Guest TM, Ramanathan AV, Tuteur PG, Schecht-man KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients. A frequently uiuecognized complication. JAMA 1995; 273: 1945-9.
51. Higgins JP, Higgins JA. Elevation of cardiac troponin i indicates more than myocardial ischaemia. Clin Invest Med 2003; 26: 133-47.
52. Čubrilo-Turek M, Topic E, Štefanović M, Vučić N, Vrkic N, Pilaš V. Evaluation of new biochemical markers for early detection of myocardial injuiy in critically ill patients. Neurol Croat 1998; 47: suppl 1: 43-7.
53. Katz IA, Irwing L, Vinen JD i sur. Biochemical markers of acute myocardial infarction; strategies for improving their clinical usefulness. Ann Clin Biochem 1998; 35; 393-9.
54. deWinter RJ, Koster RW, Sanders GT. Early exclusion of ischemic myocardial damage made possible by new biochemical cardiac markers. Nether Tijdschrift Geneeskunde 1998; 142; 940-4.
55. Koukkunen H, Penttila K, Kemppainen A i sur. Troponin T and creatine kinase isoenzyme MB mass in tile diagnosis of myocardial infarction. Ann Med 1998; 30: 488-96.
56. Kontos MC, Anderson FP, Alimard R, Omato JP, Tatum JL, Jesse RL. Ability of troponin I to predict cardiac events in patients admitted from the emergency department. J Am Coil Cardiol 2000; 36: 1818-23,
57. Kollef MH, Ladenson JH, Eisenberg PR. Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I? Chest 1997; 111; 1340-7.